Citizens keeps Market Outperform on NRC Health with $27 target
Citizens reaffirmed its Market Outperform rating on NRC Health with a $27 price target, citing quarterly revenue 7% above estimates, per TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Analysts at Citizens maintained their Market Outperform rating on NRC Health shares and set a price target of $27. According to TradingView, that target implies an upside of 24.1% from the October 27 close of $21.75.
The analyst note points to quarterly revenue of $38.4 million, which beat estimates by 7%. It also highlights the early-quarter go-live of a large patient experience customer as evidence of effective execution and an ability to win significant contracts.
why it matters
Rating reports like this usually serve as background signals: they show how one brokerage views a stock, but they rarely shift the broader market. For investors, the more relevant points are the revenue trend and the new contracts the analysts cite.
tags
instruments
sources
- Citizens maintains Market Outperform rating on NRC Health, $27 price target — TradingView, 28 October 2026 at 13:25 UTC
- Citizens maintains Market Outperform rating on Slide Insurance Holdings, $33 price target — TradingView, 28 October 2026 at 13:22 UTC
- NRC Health Is Maintained at Market Outperform by Citizens — Dow Jones Newswires, 28 October 2026 at 13:35 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗